GlassScriptPhysician profile
Ann Hall
NPI 1235602533
$3,108.57
in general payments reported to CMS, 2019-2025
33 companies · $793 in 2025
The $793 reported for 2025 was more than what 87% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $252 · 2022: $399 · 2023: $531 · 2024: $1,132 · 2025: $793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,457.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $532.74 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| W. L. Gore & Associates, INC. | $349.61 | 2022-2025 | Gore Excluder Iliac Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Vbx Balloon Expandable Endo |
| Lemaitre Vascular, INC. | $266.09 | 2022-2024 | Hydro Lemaitre Valvulotome, Trivex System, Artegraft Vascular Graft |
| Abiomed | $229.44 | 2024-2025 | Impella |
| Zimmer Biomet Holdings, INC. | $220.04 | 2025 | Venapax |
| Atricure, INC. | $171.61 | 2024-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Angiodynamics, INC. | $156.02 | 2024 | Angiovac |
| Baxter Healthcare | $150.00 | 2025 | Preveleak |
| Medical Device Business Services, INC. | $117.64 | 2024 | Vistaseal, Stratafix |
| Silk Road Medical, INC. | $103.59 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Integra Lifesciences Corporation | $90.46 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Boston Scientific Corporation | $80.88 | 2022-2025 | Enroute Transcarotid Neuroprotection System, Varithena Administration Pack |
| Kerecis Limited | $69.33 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Novartis Pharmaceuticals Corporation | $55.79 | 2021 | |
| Becton, Dickinson and Company | $54.85 | 2025 | Hemosphere |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $48.16 | 2023-2025 | Novosorb Btm |
| Medtronic, INC. | $43.94 | 2023-2024 | Corevalve Evolut R, Mvp, In.Pact Av |
| Bard Peripheral Vascular, INC. | $39.87 | 2023-2024 | Rotarexs 6 F X 135 Cm, Covera |
| Amarin Pharma, INC. | $36.86 | 2021 | |
| Teleflex LLC | $36.42 | 2021-2022 | |
| Tactile Systems Technology INC | $33.54 | 2023 | Flexitouch Plus, Entre Plus |
| Kci USA, INC. | $30.36 | 2021 | |
| Janssen Pharmaceuticals, INC | $28.63 | 2022-2023 | Xarelto |
| Endologix LLC | $23.36 | 2023 | Alto Abdominal Stent Graft System |
| Getinge USA Sales, LLC | $18.46 | 2025 | Vasoview Hemopro 2 |
| Mozarc Medical US LLC | $17.76 | 2024 | Palindrome |
| Philips North America LLC | $16.95 | 2023 | |
| Lifenet Health | $16.87 | 2024 | Theragenesis Wound Matrix |
| Smith+Nephew, INC. | $15.17 | 2023 | Renasys Go V2 Home, Pico |
| Amgen INC. | $14.83 | 2021 | |
| Solventum Corporation | $13.92 | 2025 | V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice, Prevena |
| Chiesi USA, INC. | $13.20 | 2021 | |
| Acacia Pharma INC | $12.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.